Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.

Gastroenterology - 1 Feb 2007

Hsu Chao-Wei, Yeh Chau-Ting, Chang Ming-Ling, Liaw Yun-Fan

Abstract excerpt

BACKGROUND & AIMS: Seroclearance of hepatitis B virus (HBV) surface antigen (HBsAg) is a rare event in chronic hepatitis B patients receiving lamivudine therapy. It is generally believed to be a benevolent sign, implicating clearance of viremia. The aim of this study is to examine the authenticity of this dogma. METHODS: In a 5-year period, 11 patients treated with lamivudine experienced seroclearance of HBsAg....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Surface Antigens
Share to Immunoenzyme Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Protein Precursors

Share to Radioimmunoassay

Share to Reagent Kits, Diagnostic

Share to Reverse Transcriptase Inhibitors

Share to Viremia

Source

Identifiers

PMID: 17258721
DOI: 10.1053/j.gastro.2006.12.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.PMID 17258721Read ↗

Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapySemantic proximity Read ↗

Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy.Semantic proximity Read ↗

Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia.Semantic proximity Read ↗

Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.Semantic proximity Read ↗

Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen.Semantic proximity Read ↗

Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.Semantic proximity Read ↗

Hepatitis B caused by a hepatitis B surface antigen escape mutant.Semantic proximity Read ↗

Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals.Semantic proximity Read ↗

Hepatitis B virus S gene mutants in infants infected despite immunoprophylaxis.Semantic proximity Read ↗

Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.Semantic proximity Read ↗

A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.Semantic proximity Read ↗

[Variability of Reverse Transcriptase Gene and S Gene in Lamivudine-treated Chronic Hepatitis B Patients].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.